Publications in collaboration with researchers from University College London (25)

2024

  1. Endomyocardial biopsy: safety and prognostic utility in paediatric and adult myocarditis in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Long-Term Registry

    European Heart Journal, Vol. 45, Núm. 28, pp. 2548-2569

2023

  1. Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis registry

    European Heart Journal - Quality of Care and Clinical Outcomes, Vol. 9, Núm. 1, pp. 42-53

  2. Effects of Vojta Therapy on the Motor Function of Children with Neuromotor Disorders: Study Protocol for a Randomized Controlled Trial

    Journal of Clinical Medicine, Vol. 12, Núm. 23

2022

  1. Clinical Features and Natural History of Preadolescent Nonsyndromic Hypertrophic Cardiomyopathy

    Journal of the American College of Cardiology, Vol. 79, Núm. 20, pp. 1986-1997

  2. Liver growth prediction in ALPPS – A multicenter analysis from the international ALPPS registry

    Liver International, Vol. 42, Núm. 12, pp. 2815-2829

  3. Relationship Between Maximal Left Ventricular Wall Thickness and Sudden Cardiac Death in Childhood Onset Hypertrophic Cardiomyopathy

    Circulation. Arrhythmia and electrophysiology, Vol. 15, Núm. 5, pp. e010075

2021

  1. Improving lung health in low-income and middle-income countries: from challenges to solutions

    The Lancet, Vol. 397, Núm. 10277, pp. 928-940

2020

  1. First Long-term Oncologic Results of the ALPPS Procedure in a Large Cohort of Patients With Colorectal Liver Metastases

    Annals of surgery, Vol. 272, Núm. 5, pp. 793-800

  2. Renal Impairment Is Associated with Reduced Outcome After Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy

    Journal of Gastrointestinal Surgery, Vol. 24, Núm. 11, pp. 2500-2507

  3. XAF1 as a modifier of p53 function and cancer susceptibility

    Science Advances, Vol. 6, Núm. 26

2019

  1. 10th Anniversary of ALPPS - Lessons Learned and quo Vadis

    Annals of Surgery, Vol. 269, Núm. 1, pp. 114-119

  2. Accuracy of estimated total liver volume formulas before liver resection

    Surgery (United States), Vol. 166, Núm. 3, pp. 247-253

  3. Development of a Novel Risk Prediction Model for Sudden Cardiac Death in Childhood Hypertrophic Cardiomyopathy (HCM Risk-Kids)

    JAMA Cardiology, Vol. 4, Núm. 9, pp. 918-927

  4. Performance validation of the ALPPS risk model

    HPB, Vol. 21, Núm. 6, pp. 711-721

2018

  1. Aspirin Versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia

    Obstetrical and Gynecological Survey

2017

  1. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia

    New England Journal of Medicine, Vol. 377, Núm. 7, pp. 613-622

  2. High mortality after ALPPS for perihilar cholangiocarcinoma: case-control analysis including the first series from the international ALPPS registry

    HPB, Vol. 19, Núm. 5, pp. 381-387

  3. Neoadjuvant chemotherapy does not affect future liver remnant growth and outcomes of associating liver partition and portal vein ligation for staged hepatectomy

    Surgery (United States), Vol. 161, Núm. 5, pp. 1255-1265

  4. Patient Survival After Simultaneous ALPPS and Colorectal Resection

    World Journal of Surgery, Vol. 41, Núm. 4, pp. 1119-1125

  5. Risk Adjustment in ALPPS Is Associated with a Dramatic Decrease in Early Mortality and Morbidity

    Annals of Surgery, Vol. 266, Núm. 5, pp. 779-786